n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
Top Cited Papers
- 26 July 2012
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 367 (4) , 309-318
- https://doi.org/10.1056/nejmoa1203859
Abstract
The use of n–3 fatty acids may prevent cardiovascular events in patients with recent myocardial infarction or heart failure. Their effects in patients with (or at risk for) type 2 diabetes mellitus are unknown.Keywords
This publication has 18 references indexed in Scilit:
- Basal Insulin and Cardiovascular and Other Outcomes in DysglycemiaNew England Journal of Medicine, 2012
- Cardiovascular effects of marine omega-3 fatty acidsThe Lancet, 2010
- More insights on the dysglycaemia–cardiovascular connectionThe Lancet, 2010
- Omega‐3 Dietary Supplements and the Risk of Cardiovascular Events: A Systematic ReviewClinical Cardiology, 2009
- Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: A meta-analysis of randomized controlled trialsAnnals of Medicine, 2009
- Effect of fish oil on arrhythmias and mortality: systematic reviewBMJ, 2008
- n–3 Fatty acids and cardiovascular disease: evidence explained and mechanisms exploredClinical Science, 2004
- Fish and Long-Chain ω-3 Fatty Acid Intake and Risk of Coronary Heart Disease and Total Mortality in Diabetic WomenCirculation, 2003
- Fish and Omega-3 Fatty Acid Intake and Risk of Coronary Heart Disease in WomenJAMA, 2002
- Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trialThe Lancet, 1999